HUMANISIERTE ANTIKÖRPER, DIE AMYLOID BETA PEPTID SEQUESTRIEREN

摘要

A method to treat conditions characterized by formation of amyloid plaques both prophylactically and therapeutically is described. The method employs humanized antibodies which sequester soluble A beta peptide from human biological fluids or which preferably specifically bind an epitope contained within position 13-28 of the amyloid beta peptide A beta .